Results 31 to 38 of about 45 (38)

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Hakan SentÜrk, Yilmaz Cakaloglu   +2 more
exaly  

All-cellulose composites from alfa and wood fibers

Industrial Crops and Products, 2019
Khaled Labidi, Tatiana Budtova
exaly  

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)

Journal of Hepatology, 2006
exaly  

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Blood, 2019
Abdulraheem Yacoub, John Mascarenhas, Heidi E Kosiorek   +2 more
exaly  

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

Lancet, The, 2001
exaly  

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C

Journal of Hepatology, 2004
exaly  

Darbepoetin Alfa

Drugs, 2012
exaly  

The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

Current Medical Research and Opinion, 2006
exaly